An interventional study of Antibiotics in Chronic Endometritis, sponsored by Fu Xing Hospital, Capital Medical University. Completed at 1 site in China. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2022-02-07.
Sponsored by Fu Xing Hospital, Capital Medical University · Not applicable, Interventional, and Treatment
120 cases with a diagnosis of chronic endometritis, confirmed by the presence of plasma cells in endometrial biopsy sample identified by immunohistochemical staining using CD138 antibody, have been recruited. The subjects have been randomly divided into two groups, the experimental group have been given antibiotic (Levofloxacin and Tinidazole for 14 days) treatment, the control group did not receive any antibiotic. Initially it was planned for women in the control group to take placebo,but the organization was difficult, so it was changed prior to the start of the study to an open label study. A repeat endometrial biopsy sample have been obtained 2-4 weeks after completion of the antibiotic therapy to assess the response to treatment. The conversion rate will be compared between the two groups
This study will be carried out at the Hysteroscopy centre of the Fuxing Hospital, Capital Medical University ,Beijing, China. A total of 120 women with chronic endometritis who fulfilled the following inclusion criteria will be recruited:
Exclusion Criteria:
Power calculation: Assuming that the spontaneous CD138 conversion (from positive to negative ) rate is 25% and that the antibiotic therapy results in 60% conversion rate, the total number of subjects required in each arm of the RCT will be 37, accepting a Type I error of 0.05 and a Type II error of 0.1, and assuming a drop-out rate of 20%, 45 subjects will need to be recruited into each arm. Hence, a total of 90 subjects who fulfilled the inclusion criteria will be required.
Recruitment: Women have been recruited form the day case hysteroscopy unit of the Hysteroscopy center, Fuxing Hospital, Beijing, China. The Hysteroscopy center currently carries out \~600 day case hysteroscopy per month. In all cases, endometrial biopsy specimen will be obtained at the time of hysteroscopy for histological evaluation. Since 2013, all endometrial specimens have been routinely examined with the used of CD138 antibody to establish if there is evidence of chronic endometritis, in addition to routine histopathological examination. Previous audit showed that \~15% of subjects had positive staining for CD138 cells.We recruited the initial 132 subjects according to the inclusion and exclusion criteria succesfully from July 2016 to December 2018.
Randomization:Women who had histological confirmation of CE in an endometrial biopsy specimen and who fulfilled the inclusion criteria were randomized into the antibiotic group and control group in a 1:1 ratio using a computer-generated randomization list and sealed opaque envelopes prepared by the first author. The patients were not blinded to the antibiotic treatment. The pathologist who performed the histological evaluation was blinded to the treatment.
Antibiotic therapy: Women who were randomized to the treatment group were given oral Levofloxacin and Tinidazole daily for 14 days.
Women who were randomized to the control group did not receive any antibiotic. Staff Pharmacist dispense medication.
Consent: written informed consent will be obtained
Repeat endometrial biopsy \& histological evaluation: The repeat endometrial biopsy will be performed after completion of the the antibiotic therapy. Immunohistochemical study using CD138 antibody will be performed.
53 studies on the registry are indexed under Endometritis; 9 are open to participants now.
This study's enrollment of 120 is below the median of 202 across 40 interventional studies indexed under Endometritis.
Browse Endometritis studies →Fu Xing Hospital, Capital Medical University is the lead sponsor of 17 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This group received antibiotic therapy
Drug: Antibiotics
This group did not receive antibiotic therapy
Levofloxacin Tab and Tinidazole Tab are combined in the antibiotic group
Also known as: Levofloxacin and Tinidazole
The Conversion Rate of CE (From Positive to Negative)
Subjects in antibiotic group underwent a second-look hysteroscopy and repeat endometrial biopsy for histopathological CD138 immunohistochemical examination 2-4 weeks after completion of antibiotic treatment and in the follicular phase of the following menstrual cycle. Subjects in control group underwent a second-look hysteroscopy and repeat endometrial biopsy for histopathological CD138 immunohistochemical examination \~4 weeks after recruitment in the follicular phase of the following menstrual cycle. The biopsies were graded as "negative" for CE if there was less than one plasma cell identified per 10 high-power fields (HPFs) and "positive" when there was one or more plasma cell identified per 10 HPFs. To compare the cure rate (From positive to negative) of CE in women who received antibiotic therapy (treatment group) with the spontaneous cure rate in those who did not receive antibiotic therapy (control group),
Time frame: 1-6 months
| Milestone | Antibiotic Group | Control Group |
|---|---|---|
| Started | 60 | 60 |
| Completed | 59 | 55 |
| Not completed | 1 | 5 |
| Withdrew: Protocol violation | 1 | 5 |
Subjects in antibiotic group underwent a second-look hysteroscopy and repeat endometrial biopsy for histopathological CD138 immunohistochemical examination 2-4 weeks after completion of antibiotic treatment and in the follicular phase of the following menstrual cycle. Subjects in control group underwent a second-look hysteroscopy and repeat endometrial biopsy for histopathological CD138 immunohistochemical examination \~4 weeks after recruitment in the follicular phase of the following menstrual cycle. The biopsies were graded as "negative" for CE if there was less than one plasma cell identified per 10 high-power fields (HPFs) and "positive" when there was one or more plasma cell identified per 10 HPFs. To compare the cure rate (From positive to negative) of CE in women who received antibiotic therapy (treatment group) with the spontaneous cure rate in those who did not receive antibiotic therapy (control group),
| Percentage of participants | Antibiotic Group | Control Group |
|---|---|---|
| The Conversion Rate of CE (From Positive to Negative) | 89.8 (82.2 to 97.5) | 12.7 (3.9 to 21.5) |
Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Antibiotic Group | 0/59 (0%) | 0/59 (0%) | 0/59 (0%) |
| Control Group | 0/55 (0%) | 0/55 (0%) | 0/55 (0%) |
| Age, Continuous(years) | Antibiotic Group | Control Group | Total |
|---|---|---|---|
| Mean | 31.86 ± 4.7 | 31.93 ± 4.8 | 31.89 ± 4.7 |
| Sex: Female, Male(Participants) | Antibiotic Group | Control Group | Total |
|---|---|---|---|
| Female | 60 | 60 | 120 |
| Male | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Antibiotic Group | Control Group | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 60 | 60 | 120 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 |
| White | 0 | 0 | 0 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Region of Enrollment(participants) | Antibiotic Group | Control Group | Total |
|---|---|---|---|
| China | 59 | 55 | 114 |
| BMI(kg/m^2) | Antibiotic Group | Control Group | Total |
|---|---|---|---|
| Mean | 22.91 ± 3.4 | 22.28 ± 3.5 | 22.61 ± 3.4 |
| Parity(events) | Antibiotic Group | Control Group | Total |
|---|---|---|---|
| Mean | 2.15 ± 0.9 | 2.15 ± 0.9 | 2.15 ± 0.9 |
| Miscarriage(events) | Antibiotic Group | Control Group | Total |
|---|---|---|---|
| Mean | 1.59 ± 1.0 | 1.93 ± 1.0 | 1.75 ± 1.0 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fu Xing Hospital, Capital Medical University